Skip to main content

457 Pill - beige oval, 13mm

Pill with imprint 457 is Beige, Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Caraco Pharmaceutical Laboratories.

Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 457

Carbidopa and levodopa extended release 50 mg / 200 mg 457
Carbidopa and levodopa extended release 50 mg / 200 mg 457 Front
Carbidopa and levodopa extended release 50 mg / 200 mg 457 Back

Carbidopa and Levodopa Extended Release

Imprint
457
Strength
50 mg / 200 mg
Color
Beige
Size
13.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Caraco Pharmaceutical Laboratories
National Drug Code (NDC)
62756-0457
Inactive Ingredients
microcrystalline cellulose, silicon dioxide, hydroxypropyl cellulose (type l), ferric oxide red, D&C Yellow No. 10, hypromelloses, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "457"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.